Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Echocardiography-based pressure-volume loop assessment in the evaluation for the effects of indoxyl sulfate on cardiovascular function.

Obokata M, Kurosawa K, Ishida H, Ito K, Ogawa T, Ando Y, Kurabayashi M, Negishi K.

J Echocardiogr. 2018 Jul 7. doi: 10.1007/s12574-018-0385-5. [Epub ahead of print]

PMID:
29982976
2.

Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction.

Obokata M, Reddy YNV, Melenovsky V, Kane GC, Olson TP, Jarolim P, Borlaug BA.

J Am Coll Cardiol. 2018 Jul 3;72(1):29-40. doi: 10.1016/j.jacc.2018.04.039.

PMID:
29957229
3.

Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.

Gorter TM, Obokata M, Reddy YNV, Melenovsky V, Borlaug BA.

Eur Heart J. 2018 Jun 26. doi: 10.1093/eurheartj/ehy331. [Epub ahead of print]

PMID:
29947750
4.

The strengths and limitations of E/e' in heart failure with preserved ejection fraction.

Obokata M, Borlaug BA.

Eur J Heart Fail. 2018 Jun 22. doi: 10.1002/ejhf.1250. [Epub ahead of print] No abstract available.

PMID:
29932475
5.

Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction.

Reddy YNV, Olson TP, Obokata M, Melenovsky V, Borlaug BA.

JACC Heart Fail. 2018 May 21. pii: S2213-1779(18)30203-8. doi: 10.1016/j.jchf.2018.03.003. [Epub ahead of print]

PMID:
29803552
6.

A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure with Preserved Ejection Fraction.

Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA.

Circulation. 2018 May 23. pii: CIRCULATIONAHA.118.034646. doi: 10.1161/CIRCULATIONAHA.118.034646. [Epub ahead of print]

PMID:
29792299
7.

Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction.

Obokata M, Olson TP, Reddy YNV, Melenovsky V, Kane GC, Borlaug BA.

Eur Heart J. 2018 May 19. doi: 10.1093/eurheartj/ehy268. [Epub ahead of print]

PMID:
29788047
8.

Differences between first-generation and second-generation drug-eluting stent regarding in-stent neoatherosclerosis characteristics: an optical coherence tomography analysis.

Kobayashi N, Ito Y, Yamawaki M, Araki M, Sakai T, Obokata M, Sakamoto Y, Mori S, Tsutsumi M, Nauchi M, Honda Y, Tokuda T, Makino K, Shirai S, Hirano K.

Int J Cardiovasc Imaging. 2018 May 21. doi: 10.1007/s10554-018-1375-4. [Epub ahead of print]

PMID:
29785558
9.

Stress Imaging in Heart Failure: Physiologic, Diagnostic, and Therapeutic Insights.

Obokata M, Borlaug BA.

Circ Cardiovasc Imaging. 2018 May;11(5):e007785. doi: 10.1161/CIRCIMAGING.118.007785. No abstract available.

PMID:
29748314
10.

High Prevalence of Occult Heart Failure With Preserved Ejection Fraction Among Patients With Atrial Fibrillation and Dyspnea.

Reddy YNV, Obokata M, Gersh BJ, Borlaug BA.

Circulation. 2018 Jan 30;137(5):534-535. doi: 10.1161/CIRCULATIONAHA.117.030093. No abstract available.

PMID:
29378762
11.

Response by Obokata and Borlaug to Letters Regarding Article, "Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction".

Obokata M, Borlaug BA.

Circulation. 2018 Jan 23;137(4):416-417. doi: 10.1161/CIRCULATIONAHA.117.031394. No abstract available.

PMID:
29358350
12.

Skeletal Muscle Compensation for Cardiac Muscle Insufficiency in Heart Failure and Reduced Ejection Fraction.

Reddy YNV, Obokata M, Haykowsky MJ, Borlaug BA.

Circ Heart Fail. 2018 Jan;11(1):e004714. doi: 10.1161/CIRCHEARTFAILURE.117.004714. No abstract available.

PMID:
29317402
13.

Left Ventricular Filling Pressures in Heart Failure With Preserved Ejection Fraction: Is the Tail Now Wagging the Dog?

Obokata M, Borlaug BA.

JACC Heart Fail. 2017 Nov;5(11):802-804. doi: 10.1016/j.jchf.2017.09.001. Epub 2017 Oct 11. No abstract available.

PMID:
29032134
14.

Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients.

Obokata M, Negishi K, Sunaga H, Ishida H, Ito K, Ogawa T, Iso T, Ando Y, Kurabayashi M.

J Am Heart Assoc. 2017 Oct 3;6(10). pii: e006885. doi: 10.1161/JAHA.117.006885.

15.

Robust suppression of cardiac energy catabolism with marked accumulation of energy substrates during lipopolysaccharide-induced cardiac dysfunction in mice.

Umbarawan Y, Syamsunarno MRAA, Obinata H, Yamaguchi A, Sunaga H, Matsui H, Hishiki T, Matsuura T, Koitabashi N, Obokata M, Hanaoka H, Haque A, Kunimoto F, Tsushima Y, Suematsu M, Kurabayashi M, Iso T.

Metabolism. 2017 Dec;77:47-57. doi: 10.1016/j.metabol.2017.09.003. Epub 2017 Sep 20.

16.
17.

Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.

Reddy YNV, Andersen MJ, Obokata M, Koepp KE, Kane GC, Melenovsky V, Olson TP, Borlaug BA.

J Am Coll Cardiol. 2017 Jul 11;70(2):136-148. doi: 10.1016/j.jacc.2017.05.029.

18.

Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease.

Borlaug BA, Obokata M.

Eur Heart J. 2017 Oct 7;38(38):2874-2878. doi: 10.1093/eurheartj/ehx184. No abstract available.

PMID:
28431020
19.

Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.

Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA.

Circulation. 2017 Jul 4;136(1):6-19. doi: 10.1161/CIRCULATIONAHA.116.026807. Epub 2017 Apr 5.

20.

Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease.

Reddy YNV, Obokata M, Dean PG, Melenovsky V, Nath KA, Borlaug BA.

Eur Heart J. 2017 Jun 21;38(24):1913-1923. doi: 10.1093/eurheartj/ehx045.

PMID:
28329100
21.

Incremental Prognostic Value of Ventricular-Arterial Coupling over Ejection Fraction in Patients with Maintenance Hemodialysis.

Obokata M, Kurosawa K, Ishida H, Ito K, Ogawa T, Ando Y, Kurabayashi M, Negishi K.

J Am Soc Echocardiogr. 2017 May;30(5):444-453.e2. doi: 10.1016/j.echo.2016.12.014. Epub 2017 Feb 27.

PMID:
28246005
22.

Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study.

Obokata M, Kane GC, Reddy YN, Olson TP, Melenovsky V, Borlaug BA.

Circulation. 2017 Feb 28;135(9):825-838. doi: 10.1161/CIRCULATIONAHA.116.024822. Epub 2016 Dec 30.

23.

Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction.

Obokata M, Nagata Y, Kado Y, Kurabayashi M, Otsuji Y, Takeuchi M.

J Card Fail. 2017 Mar;23(3):216-220. doi: 10.1016/j.cardfail.2016.10.001. Epub 2016 Oct 11.

PMID:
27737768
24.

Relation Between Echocardiogram-Based Cardiac Parameters and Outcome in Heart Failure With Preserved and Reduced Ejection Fraction.

Obokata M, Takeuchi M, Negishi K, Ohte N, Izumo M, Yamashita E, Ebato M, Yuda S, Kurabayashi M, Nakatani S.

Am J Cardiol. 2016 Nov 1;118(9):1356-1362. doi: 10.1016/j.amjcard.2016.07.060. Epub 2016 Aug 12.

PMID:
27600459
25.

Right ventricular dysfunction and pulmonary hypertension in heart failure with preserved ejection fraction.

Obokata M, Borlaug BA.

Eur J Heart Fail. 2016 Dec;18(12):1488-1490. doi: 10.1002/ejhf.666. Epub 2016 Oct 13. No abstract available.

26.

Effect of Sex Differences on the Association Between Stroke Risk and Left Atrial Anatomy or Mechanics in Patients With Atrial Fibrillation.

Yoshida K, Obokata M, Kurosawa K, Sorimachi H, Kurabayashi M, Negishi K.

Circ Cardiovasc Imaging. 2016 Oct;9(10). pii: e004999.

27.

Cumulative Burden of Myocardial Dysfunction in Cardiac Amyloidosis Assessed Using Four-Chamber Cardiac Strain.

Kado Y, Obokata M, Nagata Y, Ishizu T, Addetia K, Aonuma K, Kurabayashi M, Lang RM, Takeuchi M, Otsuji Y.

J Am Soc Echocardiogr. 2016 Nov;29(11):1092-1099.e2. doi: 10.1016/j.echo.2016.07.017. Epub 2016 Sep 7.

PMID:
27614542
28.

Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.

Obokata M, Sunaga H, Ishida H, Ito K, Ogawa T, Ando Y, Kurabayashi M, Negishi K.

Am Heart J. 2016 Sep;179:29-41. doi: 10.1016/j.ahj.2016.05.018. Epub 2016 Jun 18.

PMID:
27595677
29.

Direct comparison of cardiac magnetic resonance feature tracking and 2D/3D echocardiography speckle tracking for evaluation of global left ventricular strain.

Obokata M, Nagata Y, Wu VC, Kado Y, Kurabayashi M, Otsuji Y, Takeuchi M.

Eur Heart J Cardiovasc Imaging. 2016 May;17(5):525-32. doi: 10.1093/ehjci/jev227. Epub 2015 Sep 15.

PMID:
26377901
30.

A Risk Score with Additional Four Independent Factors to Predict the Incidence and Recovery from Metabolic Syndrome: Development and Validation in Large Japanese Cohorts.

Obokata M, Negishi K, Ohyama Y, Okada H, Imai K, Kurabayashi M.

PLoS One. 2015 Jul 31;10(7):e0133884. doi: 10.1371/journal.pone.0133884. eCollection 2015.

31.

Comparison of different interdialytic intervals among hemodialysis patients on their echocardiogram-based cardiovascular parameters.

Obokata M, Negishi K, Marwick TH, Kurosawa K, Ishida H, Ito K, Ogawa T, Ando Y, Kurabayashi M.

Am Heart J. 2015 Apr;169(4):523-30.e2. doi: 10.1016/j.ahj.2015.02.003. Epub 2015 Feb 12.

PMID:
25819859
32.

Left atrial strain provides incremental value for embolism risk stratification over CHA₂DS₂-VASc score and indicates prognostic impact in patients with atrial fibrillation.

Obokata M, Negishi K, Kurosawa K, Tateno R, Tange S, Arai M, Amano M, Kurabayashi M.

J Am Soc Echocardiogr. 2014 Jul;27(7):709-716.e4. doi: 10.1016/j.echo.2014.03.010. Epub 2014 Apr 24.

PMID:
24767972
33.

Fatty acid binding protein 4 and 5 play a crucial role in thermogenesis under the conditions of fasting and cold stress.

Syamsunarno MR, Iso T, Yamaguchi A, Hanaoka H, Putri M, Obokata M, Sunaga H, Koitabashi N, Matsui H, Maeda K, Endo K, Tsushima Y, Yokoyama T, Kurabayashi M.

PLoS One. 2014 Mar 6;9(6):e90825. doi: 10.1371/journal.pone.0090825. eCollection 2014.

34.

A critical role of fatty acid binding protein 4 and 5 (FABP4/5) in the systemic response to fasting.

Syamsunarno MR, Iso T, Hanaoka H, Yamaguchi A, Obokata M, Koitabashi N, Goto K, Hishiki T, Nagahata Y, Matsui H, Sano M, Kobayashi M, Kikuchi O, Sasaki T, Maeda K, Murakami M, Kitamura T, Suematsu M, Tsushima Y, Endo K, Hotamisligil GS, Kurabayashi M.

PLoS One. 2013 Nov 14;8(11):e79386. doi: 10.1371/journal.pone.0079386. eCollection 2013.

35.

Incremental diagnostic value of la strain with leg lifts in heart failure with preserved ejection fraction.

Obokata M, Negishi K, Kurosawa K, Arima H, Tateno R, Ui G, Tange S, Arai M, Kurabayashi M.

JACC Cardiovasc Imaging. 2013 Jul;6(7):749-58. doi: 10.1016/j.jcmg.2013.04.006. Epub 2013 Jun 5.

36.

Massive pleural effusion due to pleural AA amyloidosis.

Shimizu Y, Endou K, Hashizume Y, Kawata T, Horie T, Ogura H, Obokata M, Toyoda M, Ito H, Takise A.

Am J Respir Crit Care Med. 2012 Dec 15;186(12):e19-20. doi: 10.1164/rccm.201111-2079IM. No abstract available.

PMID:
23250505
37.

[Case report; a case of refractory vasospastic angina with twice CPA event related to dysfunction of autonomic nervous system, which was successfully treated with thoracic sympathectomy].

Imai M, Obokata M, Ono Y, Kobayashi N, Kuribara J, Ui G, Tange S, Kamiyoshihara M.

Nihon Naika Gakkai Zasshi. 2011 Dec 10;100(12):3634-6. Japanese. No abstract available.

PMID:
22338896
38.

Transient T-wave pseudonormalization following pheochromocytoma crisis.

Obokata M, Kaneko Y, Yagi H, Kurabayashi M.

Intern Med. 2010;49(9):873-4. Epub 2010 Apr 30. No abstract available.

Supplemental Content

Loading ...
Support Center